Skip to main content
CAS 0 records

CAS 10103-46-5

CAS 10103-46-5 matches 0 EU annex records across Annex II–VI of Regulation 1223/2009.

Records for CAS 10103-46-5

0 total
No records found for this CAS number.

Chemical identity and properties

PubChem 2D chemical structure for CAS 10103-46-5
CAS 10103-46-5PubChem CID 24456

Tricalcium Phosphate

Calcium phosphate is typically available as an over the counter supplement, antacid, or as an added ingredient in some toothpastes. — DrugBank

IUPAC name
tricalcium diphosphate
Molecular formula
Ca3O8P2
Molecular weight
310.18 g/mol
Exact mass
309.7946135 Da
Topological polar surface area
173.0 Ų
Hydrogen-bond donors
0
Hydrogen-bond acceptors
8
Covalent units
5
Defined stereocentres
0

Also known as

7758-87-4SynthosCalcium orthophosphatePhosphoric acid, calcium salt (2:3)Tricalcium orthophosphateCalcigenol simpleTertiary calcium phosphateBonarka
16 more reported names
Calcium phosphate, tribasicCalcium tertiary phosphateCalcium phosphate (3:2)Natural whitlockiteFEMA No. 3081Calcium phosphate (Ca3(PO4)2)Calcium orthophosphate, tri-(tert)Tricalcium phosphate (Ca3(PO4)2)K4C08XP666Phosphoric acid calcium(2+) salt (2:3)INS NO.341(III)INS-341(III)E-341(III)BONE POWDER, PURIFIEDcalcium phosphate, tricalcium saltRefChem:6401
External database identifiers

Evidence from additional scientific databases

NIH PubChem PUG-View
Exact identifier match24456

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: INHALATION: move to clean air; see physician in case of persistent coughing, expectoration, chest pain, or shortness of breath.; INGESTION: get medical attention quickly; induce vomiting by giving large amounts of water or warm salty water, or by tickling back of patient's throat; continue until vomitus is clear; follow with milk, eggs, or olive oil to soothe stomach.; EYES: immediately flush with large quantities of running water for at least 15 min., holding eyelids apart to insure thorough flushing of eyes and lids; do not attempt to neutralize with chemical agents; get medical attention quickly; if physician is (USCG, 1999) Source: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 95.7% (529 of 553) of all reports. Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 529 of 553 companies (only 4.3% companies provided GHS information). For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 553 reports by companies from 6 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 529 of 553 reports by companies.; There are 4 notifications provided by 24 of 553 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Note: This chemical does not meet GHS hazard criteria for 75% (27 of 36) of all reports. Source: European Chemicals Agency (ECHA)
  • Signal: Danger Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H318 (25%): Causes serious eye damage [Danger Serious eye damage/eye irritation] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264+P265, P280, P305+P354+P338, and P317 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 36 reports by companies from 2 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 27 of 36 reports by companies.; There is 1 notification provided by 9 of 36 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following 31 ingredients are safe in the present practices of use and concentration in cosmetics as described in this safety assessment, when formulated to be non-irritating...Calcium Phosphate... Source: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications Source: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following 31 ingredients are safe in the present practices of use and concentration in cosmetics as described in this safety assessment, when formulated to be non-irritating...Tricalcium Phosphate... Source: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: IDENTIFICATION AND USE: White amorphous, or crystaline powder. It is odorless and tasteless. It is practically insoluble in alcohol, and acetic acid, and soluble in dilute hydrochloric acid, and nitric acid. Slightly soluble in water. It is used in the manufacture of fertilizers, phosphate compounds, manufacture of milk glass, polishing and dental powders, porcelains, pottery, enameling; clarifying sugar syrups; in animal feeds; as noncaking agent; in textile industry. It is used as a stabilizer in plastics; in meat tenderizers; in food as a buffer and used in medical applications as a calcium replenisher. It veterinary medicine it is used as a dietary supplement and an antacid. It is used in the manufacture of luminescent materials. HUMAN EXPOSURE AND TOXICITY: Tricalcium phosphate is not irritating and toxic doses by ingestion would have to be more than 2 g/kg. Skin sensitization is unusual. Aspiration or inhalation could cause chemical pneumonitis. Implantation of material will cause foreign body reaction. Tricalcium phosphate is contraindicated in treatment of hypocalcemia with hyperphosphatemia which may occur in hypoparathyroidism and renal failure. ANIMAL STUDIES: Tricalcium Source: Hazardous Substances Data Bank (HSDB)

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status
SourceResultChecked
EMBL-EBI ChEBINo exact record2026-08-31
NIH PubChem PUG-ViewExact match2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

How CAS 10103-46-5 is used on this site

CAS 10103-46-5 is the Chemical Abstracts Service identifier used to pin this page to a specific substance. In the current dataset, 0 EU annex records share this identifier, which helps you cross-check whether the same substance appears under one regulatory context or several.

Use this page when a supplier specification, SDS or raw-material dossier gives you CAS 10103-46-5 and you need to see every linked Annex II–VI record in one place. The entry cards above are the quickest route to concentration limits, warnings, annex placement and product-type conditions.